The overexpression of DDAH2 improves myocardial fibrosis and cardiac function by activating the DDAH/ADMA/eNOS/NO pathway, thereby delaying the progression of DCM [190]. This evidence concerns the gene NOS3 and familial dilated cardiomyopathy.